Mohammad Askandar Iqbal

Years Active: 2018-2021
Publications (10 Years): 4

This page only lists publications with an associated author ORCID identifier.

Publications

Asifa Khan, Shumaila Siddiqui, Syed Akhtar Husain, Sybille Mazurek, Mohammad Askandar Iqbal
Phytocompounds Targeting Metabolic Reprogramming in Cancer: An Assessment of Role, Mechanisms, Pathways, and Therapeutic Relevance. Journal of agricultural and food chemistry (2021)
Mohammad Askandar Iqbal, Shumaila Siddiqui, Asad Ur Rehman, Farid Ahmad Siddiqui, Prithvi Singh, Bhupender Kumar, Daman Saluja
Multiomics integrative analysis reveals antagonistic roles of CBX2 and CBX7 in metabolic reprogramming of breast cancer. Molecular oncology 15 (5) (2021)
Mohammad Askandar Iqbal, Shilpi Chattopadhyay, Farid Ahmad Siddiqui, Asad Ur Rehman, Shumaila Siddiqui, Gopinath Prakasam, Asifa Khan, Sarwat Sultana, Rameshwar Nk Bamezai
Silibinin induces metabolic crisis in triple-negative breast cancer cells by modulating EGFR-MYC-TXNIP axis: potential therapeutic implications. The FEBS journal 288 (2) (2020)
Farid Ahmad Siddiqui, Gopinath Prakasam, Shilpi Chattopadhyay, Asad Ur Rehman, Rayees Ahmad Padder, Mohammad Afaque Ansari, Rasha Irshad, Kailash Mangalhara, Rameshwar N K Bamezai, Mohammad Husain, Syed Mansoor Ali, Mohammad Askandar Iqbal
Curcumin decreases Warburg effect in cancer cells by down-regulating pyruvate kinase M2 via mTOR-HIF1α inhibition. Scientific reports 8 (1) (2018)

Mohammad Askandar Iqbal.css-eqlu8i{font-size:small;padding-left:4px;}